HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II

Clinical trial NCT00291928 · COMPLETED

Trial details

NCT number: NCT00291928
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2005-02-01
Primary completion: 2007-09-01
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.